Skip to main content
SpringerLink
Log in
Book cover

Sexually Transmitted Diseases pp 21–46Cite as

Human Papillomavirus and Genital Warts

  • Chapter

Part of the book series: Current Clinical Practice ((CCP))

Abstract

Unknown until the second half of the 20th century, human papillomavirus (HPV) is now recognized as being one of the most common sexually transmitted infections (STI) in the United States, accounting for more than one-third of the new cases of STIs each year (1). HPV is a group of more than 120 viruses, at least 30 types of which can infect the anogenital areas. Most HPV infections cause no symptoms, other types can cause genital warts, and still others cause invasive squamous cell anogenital carcinoma. The total health care costs for HPV-related disease in 1998 were estimated to be $3.4 billion, two-thirds of which were spent on prevention and screening (2). This chapter provides an overview of HPV infection—its transmissibility and epidemiology. It focuses on genital warts in its discussion of the clinical consequences of HPV infection. The contribution HPV infection makes to various genital cancers is mentioned, but the screening, diagnosis, and treatments of these conditions are outside the scope of this book.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. The Henry J. Kaiser Family Foundation. Fact Sheet: Sexually Transmitted Diseases in the U.S. Available from: http://www.kff.org/womenshealth/1447-stdfs.cfm. Accessed Nov. 24, 2006.

  2. Insinga RP, Glass AG, Rush BB. The health care costs of cervical human papillomavirusrelated disease. Am J Obstet Gynecol 2004; 191:114–120.

    Article  PubMed  Google Scholar 

  3. Gerberding JL. Report to Congress: prevention of genital human papillomavirus infection. Centers for Disease Control and Prevention, Department of Health and Human Services; 2004.

    Google Scholar 

  4. Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis 1999; 26:S2–S7.

    Google Scholar 

  5. Myers ER, McCrory DC, Nanda K, Bastian L, Matchar DB. Mathematical model for the natural history of human papillomavirus infection and cervical carcinogenesis. Am J Epidemiol 2000; 151:1158–1171.

    Article  CAS  PubMed  Google Scholar 

  6. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6–10.

    Article  PubMed  Google Scholar 

  7. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998; 338:423–428.

    Article  CAS  PubMed  Google Scholar 

  8. Silins I, Kallings I, Dillner J. Correlates of the spread of human papillomavirus infection. Cancer Epidemiol Biomarkers Prev 2000; 9:953–959.

    CAS  PubMed  Google Scholar 

  9. Sellors JW, Mahony JB, Kaczorowski J, et al. Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group. CMAJ 2000; 163:503–508.

    CAS  PubMed Central  PubMed  Google Scholar 

  10. Centers for Disease Control and Prevention. CDC fact sheet: genital HPV infection. Available from: http://www.cdc.gov/std/HPV/STDFact-HPV.htm#common. Accessed Nov. 24, 2006.

  11. Baldwin SB, Wallace DR, Papenfuss MR, et al. Human papillomavirus infection in men attending a sexually transmitted disease clinic. J Infect Dis 2003; 187:1064–1070.

    Article  PubMed  Google Scholar 

  12. Takahashi S, Shimizu T, Takeyama K, et al. Detection of human papillomavirus DNA on the external genitalia of healthy men and male patients with urethritis. Sex Transm Dis 2003; 30:629–633.

    Article  PubMed  Google Scholar 

  13. Conley LJ, Ellerbrock TV, Bush TJ, Chiasson MA, Sawo D, Wright TC. HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study. Lancet 2002; 359:108–113.

    Article  PubMed  Google Scholar 

  14. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: the Young Women’s Health study. J Infect Dis 2002; 186: 462–469.

    Article  PubMed  Google Scholar 

  15. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997; 102: 3–8.

    Article  CAS  PubMed  Google Scholar 

  16. Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol 2003; 189:S3–S11.

    Article  PubMed  Google Scholar 

  17. Fleischer AB Jr, Parrish CA, Glenn R, Feldman SR. Condylomata acuminata (genital warts): patient demographics and treating physicians. Sex Transm Dis 2001; 28:643–647.

    Article  PubMed  Google Scholar 

  18. Sellors JW, Karwalajtys TL, Kaczorowski J, et al. Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ 2003; 168:421–425.

    PubMed Central  PubMed  Google Scholar 

  19. Bauer HM, Hildesheim A, Schiffman MH, et al. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis 1993; 20:274–278.

    Article  CAS  PubMed  Google Scholar 

  20. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348:518–527.

    Article  PubMed  Google Scholar 

  21. Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer 2003; 107:804–810.

    Article  CAS  PubMed  Google Scholar 

  22. Marrazzo JM, Koutsky LA, Stine KL, et al. Genital human papillomavirus infection in women who have sex with women. J Infect Dis 1998; 178:1604–1609.

    Article  CAS  PubMed  Google Scholar 

  23. Cox T, Buck HW, Kinney W, Rubin MM. HPV types: natural history and epidemiology. Human papillomavirus (HPV) and cervical cancer. Clinical proceedings. Washington, DC: Association of Reproductive Health Professionals; 2001. Available from: http://ww.arhp.org/healthcareproviders/onlinepublications/clinicalproceedings/cphpv/types.cfm?ID=149. Accessed Nov. 24, 2006.

    Google Scholar 

  24. Mao C, Hughes JP, Kiviat N, et al. Clinical findings among young women with genital human papillomavirus infection. Am J Obstet Gynecol 2003; 188:677–684.

    Article  PubMed  Google Scholar 

  25. Byars RW, Poole GV, Barber WH. Anal carcinoma arising from condyloma acuminata. Am Surg 2001; 67:469–472.

    CAS  PubMed  Google Scholar 

  26. Perniciaro C, Dicken CH. Tanning bed warts. J Am Acad Dermatol 1988; 18:586–587.

    Article  CAS  PubMed  Google Scholar 

  27. Gunter J. Genital and perianal warts: new treatment opportunities for human papillomavirus infection. Am J Obstet Gynecol 2003; 189:S3–S11.

    Article  PubMed  Google Scholar 

  28. Arany I, Evans T, Tyring SK. Tissue specific HPV expression and downregulation of local immune responses in condylomas from HIV seropositive individuals. Sex Transm Infect 1998; 74:349–353.

    Article  CAS  PubMed  Google Scholar 

  29. Stubenrauch F, Laimins LA. Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 1999; 9:379–386.

    Article  CAS  PubMed  Google Scholar 

  30. Blackledge FA, Anand VK. Tracheobronchial extension of recurrent respiratory papillomatosis. Ann Otol Rhinol Laryngol 2000; 109:812–818.

    CAS  PubMed  Google Scholar 

  31. Silverberg MJ, Thorsen P, Lindeberg H, Grant LA, Shah KV. Condyloma in pregnancy is strongly predictive of juvenile-onset recurrent respiratory papillomatosis. Obstet Gynecol 2003; 101:645–652.

    Article  PubMed  Google Scholar 

  32. Rubin MA, Kleter B, Zhou M, et al. Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 2001; 159:1211–1218.

    Article  CAS  PubMed  Google Scholar 

  33. Munoz N, Bosch FX, de Sanjose S, et al. International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003 Feb 6;348(6):518–527.

    Article  PubMed  Google Scholar 

  34. Wright TC, Cox JT. Clinical Uses of Human Papilloma Virus (HPV) DNA Testing. Hagerstown, MD: American Society for Colposcopy and Cervical Pathology; 2004.

    Google Scholar 

  35. Winer RL, Kiviat NB, Hughes JP, et al. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191:731–738.

    Article  PubMed  Google Scholar 

  36. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin 2002; 52:342–362.

    Article  PubMed  Google Scholar 

  37. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2006. MMWR Recomm Rep. 2006; 55(RR-11):62–67. Available from: http://www.cdc.gov/std/treatment. Accessed Nov. 24, 2006.

    Google Scholar 

  38. Langley PC, Richwald GA, Smith MH. Modeling the impact of treatment options in genital warts: patient-applied versus physician-administered therapies. Clin Ther 1999; 21:2143–2155.

    Article  CAS  PubMed  Google Scholar 

  39. Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician 2004; 70:2335–2342.

    PubMed  Google Scholar 

  40. Lacey CJ, Goodall RL, Tennvall GR, et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003; 79:270–275.

    Article  CAS  PubMed  Google Scholar 

  41. Alam M, Stiller M. Direct medical costs for surgical and medical treatment of condylomata acuminata. Arch Dermatol 2001; 137:337–341.

    CAS  PubMed  Google Scholar 

  42. Dahl MV. Imiquimod: an immune response modifier. J Am Acad Dermatol 2000; 43:S1–S5.

    Article  CAS  PubMed  Google Scholar 

  43. Tyring SK, Arany I, Stanley MA, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998; 178: 551–555.

    Article  CAS  PubMed  Google Scholar 

  44. Edwards L, Ferenczy A, Eron L, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998; 134:25–30.

    Article  CAS  PubMed  Google Scholar 

  45. Maw RD. Treatment of anogenital warts. Dermatol Clin 1998; 16:829–834.

    Article  CAS  PubMed  Google Scholar 

  46. Carrasco D, van der Straten M, Tyring SK. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions. J Am Acad Dermatol 2002; 47:S212–S216.

    Article  PubMed  Google Scholar 

  47. Linnehan MJ, Groce NE. Psychosocial and educational services for female college students with genital human papillomavirus infection. Farn Plann Perspect 1999; 31:137–141.

    Article  CAS  Google Scholar 

  48. Campion MJ, Brown JR, McCance DJ, et al. Psychosexual trauma of an abnormal cervical smear. Br J Obstet Gynaecol 1988; 95:175–181.

    Article  CAS  PubMed  Google Scholar 

  49. Filiberti A, Tamburini M, Stefanon B, et al. Psychological aspects of genital human papillomavirus infection: a preliminary report. J Psychosom Obstet Gynecol 1993; 14:145–152.

    Article  CAS  Google Scholar 

  50. Guy H. Survey shows how we live with HPV. HPV news. 1993; 3:1, 4–8.

    Google Scholar 

  51. Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645–1651.

    Article  CAS  PubMed  Google Scholar 

  52. Goldenthal KL, Pratt DR. FDA briefing document # 2. Preventive human papillomavirus (HPV) vaccines—background information. Bethesda, MD: Vaccines and Related Biological Products Advisory Committee; November 28–29, 2001.

    Google Scholar 

  53. Harper DM, Franco EL, Wheeler C, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 2004; 364:1757–1765.

    Article  CAS  PubMed  Google Scholar 

  54. Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271–278.

    Article  PubMed  Google Scholar 

  55. National Institute of Allergy and Infectious Diseases. Workshop summary: scientific evidence on condom effectiveness for sexually transmitted disease (STD) prevention. Washington, DC: National Institutes of Health, Department of Health Services, 2001. Available from: http://www.niaid.nih.gov/dmid/stds/condomreport.pdf. Accessed Nov. 24, 2006.

  56. Winer RL, Hughes JP, Feng Q, et al. Condom use and the risk of genital human papillomavirus infection in young women. N Engl J Med 2006; 354:2645–2654.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Nursing, College of Health & Human Services, California State University, Dominguez Hills, Carson, CA

    Linda Goldman RN, MSN, FNP (Family Nurse Practitioner, Women’s Health Care Nurse Practitioner, Nurse Practitioner)

  2. Women’s Health Care Nurse Practitioner Program, Harbor UCLA Medical Center, Torrance, CA

    Linda Goldman RN, MSN, FNP (Family Nurse Practitioner, Women’s Health Care Nurse Practitioner, Nurse Practitioner)

  3. Axminster Medical Group, Obstetrics and Gynecology Office, Inglewood, CA

    Linda Goldman RN, MSN, FNP (Family Nurse Practitioner, Women’s Health Care Nurse Practitioner, Nurse Practitioner)

Authors
  1. Linda Goldman RN, MSN, FNP
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Harbor/UCLA Medical Center, Torrance, CA

    Anita L. Nelson MD

  2. Health Care Partners, Redondo Beach, CA

    JoAnn Woodward RNC, BSN, NP

  3. Harbor/UCLA Nurse Practitioner Program, Torrance, CA

    JoAnn Woodward RNC, BSN, NP

  4. National Association of Nurse Practitioners in Women’s Health, Washington, DC

    Susan Wysocki RNC, NP, FAANP (President and CEO) (President and CEO)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc.,Totowa NJ

About this chapter

Cite this chapter

Goldman, L. (2006). Human Papillomavirus and Genital Warts. In: Nelson, A.L., Woodward, J., Wysocki, S. (eds) Sexually Transmitted Diseases. Current Clinical Practice. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-040-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-040-9_2

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-58829-570-5

  • Online ISBN: 978-1-59745-040-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation